5 Cheap Biotech Stocks To Buy

4. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 77

P/E ratio as of January 22: 8.64

Pfizer Inc. (NYSE:PFE) is a biotech company based in New York. It manufactures and distributes biopharmaceutical products across the globe.

Wells Fargo analyst Mohit Bansal holds an Equal Weight rating on Pfizer Inc. (NYSE:PFE) shares as of January 17.

Pfizer Inc. (NYSE:PFE) has sported a healthy dividend for about 12 years now, with a yield of 3.64% as of January 22. The company’s P/E ratio of 8.64 sits well below the average P/E for the biotech sector, which is 14.9. Analysts on Wall Street also see upside potential in the stock, with Wells Fargo currently holding a $50 price target on the stock, while the stock’s share price stands at $45.11.

Pfizer Inc. (NYSE:PFE) was found among the 13F holdings of 77 hedge funds in the third quarter. Their total stake value was $2.4 billion.